W.l.gore & Associates
Clinical trials sponsored by W.l.gore & Associates, explained in plain language.
-
New mesh study aims to reduce hernia recurrence over 5 years
Disease control OngoingThis study follows 320 people who had ventral or incisional hernia repair using GORE SYNECOR biomaterial mesh. Researchers will track hernia recurrence, infections, and other complications for up to 5 years. The goal is to see how well the mesh works in real-world settings across…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 25, 2026 01:53 UTC
-
New stent aims to fix dangerous aortic bulges without major surgery
Disease control OngoingThis study tests a special stent device (GORE EXCLUDER) to treat thoracoabdominal and pararenal aortic aneurysms—bulges in the main artery that can rupture. About 102 people will receive the stent through a minimally invasive procedure. Researchers will check if the device is pla…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 25, 2026 01:53 UTC
-
Real-world check for GORE TAMBE device in tough aortic aneurysms
Disease control ENROLLING_BY_INVITATIONThis study follows 300 people who received the GORE TAMBE device to treat complex aortic aneurysms. The goal is to confirm the device works safely and effectively outside of clinical trials. Researchers will track technical success and patient outcomes over 12 months.
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 24, 2026 11:07 UTC
-
New stent aims to fix aortic aneurysms without open surgery
Disease control OngoingThis study is testing a new stent device called the GORE® TAG® Thoracic Branch Endoprosthesis to treat aneurysms or lesions in the aortic arch and upper part of the main artery from the heart. About 250 participants will receive the device to see if it is safe and effective. The …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New stent aims to open blocked veins and heal leg ulcers
Disease control OngoingThis trial is testing a new stent (a small mesh tube) to treat blockages in the large vein in the abdomen (inferior vena cava) and nearby leg veins. The study involves 136 adults with symptoms like leg ulcers, pain, or swelling. Doctors will place the stent to keep the vein open …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Heart-Device study aims to stop strokes in patients with a hole in the heart
Disease control OngoingThis study is checking how well a device called the GORE® CARDIOFORM Septal Occluder works and how safe it is for people who have had a stroke caused by a hole in the heart (PFO). Researchers will follow 300 patients in Japan for 12 months after the device is implanted. The goal …
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New stent graft could fix Life-Threatening aorta tears without open surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a special tube called a stent graft to repair damage in the upper part of the main artery from the heart (the ascending aorta). It is for people with bulges (aneurysms), tears (dissections), or other lesions that usually need open-heart surgery. The goal is to se…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC
-
New stent graft offers hope for complex aortic aneurysm patients
Disease control APPROVED_FOR_MARKETINGThis study provides expanded access to a stent graft device for people with thoracoabdominal or pararenal aortic aneurysms. Participants must have an aneurysm at least 5 cm wide, a saccular aneurysm, or one growing rapidly. The device is placed inside the aorta to reinforce the v…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
New implant offers hope for glaucoma patients failing drops
Disease control OngoingThis early study tests a new device called the GORE Glaucoma Drainage Implant in 30 adults with primary open-angle glaucoma that eye drops cannot control or who are at high risk of scarring from standard surgery. The goal is to see if the implant safely lowers eye pressure by at …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New heart valve device offers hope for patients with congenital defects
Disease control OngoingThis study is testing a new device called the GORE PV1 to replace the pulmonary valve and rebuild the right ventricular outflow tract in people with congenital heart defects. The device is designed to improve blood flow from the heart to the lungs. The study includes 15 participa…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 02, 2026 11:39 UTC
-
New registry tracks Stent-Graft safety in thousands of patients
Knowledge-focused OngoingThis study is tracking over 600 people who received the GORE VIABAHN stent-graft as part of their normal medical care for conditions like peripheral artery disease or aneurysms. Researchers are monitoring how often serious device-related problems occur. The goal is to see how saf…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 25, 2026 01:52 UTC
-
Massive global study monitors aortic stent safety in 4,600 patients
Knowledge-focused OngoingThis study is a large registry that collects real-world information on how well Gore aortic stent grafts work and what complications may occur. It follows about 4,600 people who need a minimally invasive repair of an aortic aneurysm or other aortic condition. The goal is to track…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC
-
New registry monitors VBX stent graft in Real-World use
Knowledge-focused OngoingThis study is a registry that collects safety and performance data on the GORE® VIABAHN® VBX Stent Graft when used in peripheral vessels. It involves 280 adults who need this device to treat peripheral vascular disease. The goal is to see how well the stent graft works and if the…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC